Delisting risk
QSI · NASDAQ · Medical - Devices

Quantum-Si (QSI)

Builds benchtop systems, kits, and software for research-use protein sequencing.

$0.7676
Pre-market+0.00 (+0.04%)
At close$0.7673(+1.32%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000111111000
Cost of revenue000001000000
Gross profit000001000000
272824272831262725212426
Research & development171612141617141514111416
111212121214121211101010
General & administrative0000000000010
Operating income−27−28−23−26−28−31−25−27−24−21−24−26
26433−26−2−11322
Interest income000000200022
Other non-operating income0−15−4−3−32000000
Income before tax−25−22−19−23−25−33−19−29−36−18−22−24
Income tax expense000000000000
Net income from continuing operations−25−22−19−23−25−33−19−29−36−18−22−24
Net income−25−22−19−23−25−33−19−29−36−18−22−24
EPS, basic−$0.17−$0.16−$0.14−$0.16−$0.18−$0.23−$0.11−$0.16−$0.17−$0.08−$0.10−$0.11
EPS, diluted−$0.17−$0.16−$0.14−$0.16−$0.18−$0.23−$0.11−$0.16−$0.17−$0.08−$0.10−$0.11
Weighted average shares, basic142142142142142146182184209198216218
Weighted average shares, diluted142142142142142146182184209198216218
EBITDA−26−12−18−22−24−32−24−26−23−20−23−26
Depreciation & amortization111111111110
EBIT−27−13−19−23−25−33−25−27−24−21−24−26